Condition

Thyroid Eye Disease, TED clinical trials and research

• 11Clinical trials
• 1New in 30 days
• 5Countries

Newest Thyroid Eye Disease, TED clinical trials

All recruiting trials (11)

• ETHY-001 safety and activity in Thyroid Eye Disease (TED)

  This study tests ETHY-001 versus placebo to see if it is safe, tolerable, and shows activity in people with thyroid eye disease.

  Recruiting at 2 sites Phase 1 Ethyreal Bio, Inc. · Orland Park, Illinois and 2 other locations · NCT07885605

• Early risk stratification of thyroid eye disease in newly diagnosed Graves' disease

  This study tests whether early eye-related signs, blood and tear biomarkers, or eye surface features can predict who with Graves’ disease will develop thyroid eye disease within a year.

  Recruiting University of Copenhagen · Herlev · NCT07812194

• Linsitinib in moderate to severe Thyroid Eye Disease (TED)

  This study tests whether linsitinib can help people with moderate to severe TED associated with Graves' disease or Hashimoto's thyroiditis.

  Recruiting at 17 sites Phase 3 Sling Therapeutics, Inc. · Glendale, Arizona and 17 other locations · NCT07753603

• MHB018A injections for chronic moderate-to-severe thyroid eye disease

  This study tests whether MHB018A injections work better than a placebo for adults with chronic moderate-to-severe thyroid eye disease.

  Recruiting Phase 3 Minghui Pharmaceutical (Hangzhou) Ltd · Coral Gables, Florida · NCT07622121

• Treating Active Thyroid Eye Disease with MHB018A vs placebo

  In people with active moderate-to-severe TED, this study tests whether an antibody called MHB018A can help reduce eye inflammation and swelling compared with a placebo.

  Recruiting Phase 3 Minghui Pharmaceutical (Hangzhou) Ltd · Coral Gables, Florida · NCT07622108

• Cizutamig in thyroid eye disease for adults

  This study tests how safe and potentially effective cizutamig is in adults with active thyroid eye disease.

  Recruiting at 14 sites Phase 1 Candid Therapeutics · Hefei, Anhui and 13 other locations · NCT07597200

• Tofacitinib for steroid‑resistant moderate-to-severe thyroid eye disease

  This will test whether taking oral tofacitinib (5 mg twice daily) for 24 weeks can reduce eye bulging and inflammation in adults with moderate-to-severe thyroid eye disease who don't respond to or cannot take high-dose steroids.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT07547930

• KRIYA-586 (VV-14305) for Thyroid Eye Disease

  Aimed at adults with thyroid eye disease, the study tests whether VV-14305 can be safely given and help improve eye symptoms.

  Recruiting at 5 sites Phase 1/2 Kriya Therapeutics, Inc. · Livonia, Michigan and 4 other locations · NCT07404111

• Atorvastatin and vitamin D for active thyroid eye disease

  This trial tests whether taking atorvastatin and/or vitamin D with usual care can reduce eye inflammation and bulging in adults with active thyroid eye disease.

  Recruiting Taipei Veterans General Hospital, Taiwan · Taipei, Taiwan · NCT07400757

• Extended MHB018A treatment for thyroid eye disease

  This extension tries continued MHB018A injections to reduce eye bulging (proptosis) in adults with moderate-to-severe thyroid eye disease who previously received placebo.

  Recruiting Phase 3 Minghui Pharmaceutical (Hangzhou) Ltd · Shanghai, Shanghai Municipality · NCT07262476

• Evaluating GenSci098 for treating active thyroid eye disease

  This study is testing a new treatment called GenSci098 to see if it is safe and helpful for people with active thyroid eye disease linked to Graves' disease.

  Recruiting Phase 1 Changchun GeneScience Pharmaceutical Co., Ltd. · Shanghai, Shanghai Municipality · NCT06569758

Related topics

Quick answers

How many Thyroid Eye Disease, TED clinical trials are recruiting right now?

11, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 5 countries. The most sites are in United States (5 trials), China (4 trials), New Zealand (1 trial), Taiwan (1 trial), Denmark (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 4, Phase 1: 3, Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →